{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T18:31:52Z","timestamp":1767897112382,"version":"3.49.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100007547","name":"Fourth Military Medical University","doi-asserted-by":"publisher","award":["2021YFJH014"],"award-info":[{"award-number":["2021YFJH014"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100007547","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mater Sci: Mater Med"],"DOI":"10.1007\/s10856-025-06986-0","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T04:16:26Z","timestamp":1766549786000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of cellular immune response and biosafety of SV40 virus-like particle in tumor immunotherapy"],"prefix":"10.1007","volume":"37","author":[{"given":"Ting","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruoxuan","family":"Hei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaowei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5734-2373","authenticated-orcid":false,"given":"Ke","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2976-6874","authenticated-orcid":false,"given":"Juan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"key":"6986_CR1","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/smll.201301393","volume":"10","author":"F Li","year":"2014","unstructured":"Li F, Wang Q. Fabrication of nanoarchitectures templated by virus-based nanoparticles: strategies and applications. Small (Weinh der Bergstr, Ger). 2014;10:230\u201345.","journal-title":"Small (Weinh der Bergstr, Ger)"},{"key":"6986_CR2","doi-asserted-by":"publisher","first-page":"10482","DOI":"10.1021\/acsnano.2c01283","volume":"16","author":"M Li","year":"2022","unstructured":"Li M, Liang Z, Chen C, Yu G, Yao Z, Guo Y, et al. Virus-Like Particle-Templated Silica-Adjuvanted Nanovaccines with Enhanced Humoral and Cellular Immunity. ACS nano. 2022;16:10482\u201395.","journal-title":"ACS nano"},{"key":"6986_CR3","doi-asserted-by":"publisher","first-page":"9084","DOI":"10.1039\/D3TB01112G","volume":"11","author":"Y Su","year":"2023","unstructured":"Su Y, Huang LB, Teng Z, Yang Z, Zhu L, Huo J, et al. A. Virus-like particles nanoreactors: from catalysis towards bio-applications. J Mater Chem B. 2023;11:9084\u201398.","journal-title":"J Mater Chem B"},{"key":"6986_CR4","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1002\/ps.7514","volume":"79","author":"Q Xue","year":"2023","unstructured":"Xue Q, Taning SL. CNT. Plant and insect virus-like particles: emerging nanoparticles for agricultural pest management. Pest Manag Sci. 2023;79:2975\u201391.","journal-title":"Pest Manag Sci"},{"key":"6986_CR5","doi-asserted-by":"publisher","first-page":"27891","DOI":"10.1021\/acsnano.4c04212","volume":"18","author":"S Li","year":"2024","unstructured":"Li S, Yang H, Tian F, Li W, Wang H, Shi X, et al. Unveiling the Dynamic Mechanism of SARS-CoV-2 Entry Host Cells at the Single-Particle Level. ACS nano. 2024;18:27891\u2013904.","journal-title":"ACS nano"},{"key":"6986_CR6","doi-asserted-by":"publisher","first-page":"4629","DOI":"10.1021\/acs.molpharmaceut.0c00834","volume":"17","author":"H Hu","year":"2020","unstructured":"Hu H, Steinmetz NF. Cisplatin Prodrug-Loaded Nanoparticles Based on Physalis Mottle Virus for Cancer Therapy. Mol Pharm. 2020;17:4629\u201336.","journal-title":"Mol Pharm"},{"key":"6986_CR7","doi-asserted-by":"publisher","first-page":"12642","DOI":"10.1021\/acsnano.9b08756","volume":"14","author":"EJ Hartzell","year":"2020","unstructured":"Hartzell EJ, Lieser RM, Sullivan MO, Chen W. Modular Hepatitis B Virus-like Particle Platform for Biosensing and Drug Delivery. ACS Nano. 2020;14:12642\u201351.","journal-title":"ACS Nano"},{"key":"6986_CR8","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1021\/acsnano.0c08430","volume":"15","author":"SK Chan","year":"2021","unstructured":"Chan SK, Du P, Ignacio C, Mehta S, Newton IG, Steinmetz NF. Biomimetic Virus-Like Particles as Severe Acute Respiratory Syndrome Coronavirus 2 Diagnostic Tools. ACS nano. 2021;15:1259\u201372.","journal-title":"ACS nano"},{"key":"6986_CR9","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.addr.2020.06.024","volume":"156","author":"YH Chung","year":"2020","unstructured":"Chung YH, Cai H, Steinmetz NF. Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications. Adv Drug Deliv Rev. 2020;156:214\u201335.","journal-title":"Adv Drug Deliv Rev"},{"key":"6986_CR10","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/eji.200636959","volume":"38","author":"J Bessa","year":"2008","unstructured":"Bessa J, Schmitz N, Hinton HJ, Schwarz K, Jegerlehner A, Bachmann MF. Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design. Eur J Immunol. 2008;38:114\u201326.","journal-title":"Eur J Immunol"},{"key":"6986_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45495-6","volume":"15","author":"PJ Halfmann","year":"2024","unstructured":"Halfmann PJ, Loeffler K, Duffy A, Kuroda M, Yang JE, Wright ER, et al. Broad protection against clade 1 sarbecoviruses after a single immunization with cocktail spike-protein-nanoparticle vaccine. Nat Commun. 2024;15:1284.","journal-title":"Nat Commun"},{"key":"6986_CR12","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/s44222-024-00231-z","volume":"2","author":"AO Omole","year":"2024","unstructured":"Omole AO, Zhao Z, Chang-Liao S, Affonso de Oliveira JF, Boone CE, Sutorus L, et al. Virus nanotechnology for intratumoural immunotherapy. Nat Rev Bioeng. 2024;2:916\u201329.","journal-title":"Nat Rev Bioeng"},{"key":"6986_CR13","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1126\/science.abg6155","volume":"373","author":"M Segel","year":"2021","unstructured":"Segel M, Lash B, Song J, Ladha A, Liu CC, Jin X, et al. Mammalian retrovirus-like protein PEG10 packages its own mRNA and can be pseudotyped for mRNA delivery. Science (NY, N Y). 2021;373:882\u20139.","journal-title":"Science (NY, N Y)"},{"key":"6986_CR14","doi-asserted-by":"publisher","first-page":"21872","DOI":"10.1021\/acsami.2c01028","volume":"14","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Li Z, Voyer J, Li Y, Chen X. Flagellin\/Virus-like Particle Hybrid Platform with High Immunogenicity, Safety, and Versatility for Vaccine Development. ACS Appl Mater Interfaces. 2022;14:21872\u201385.","journal-title":"ACS Appl Mater Interfaces"},{"key":"6986_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00648-4","volume":"8","author":"F Tarr\u00e9s-Freixas","year":"2023","unstructured":"Tarr\u00e9s-Freixas F, Aguilar-Gurrieri C, Rodr\u00edguez de la Concepci\u00f3n ML, Urrea V, Trinit\u00e9 B, Ortiz R, et al. An engineered HIV-1 Gag-based VLP displaying high antigen density induces strong antibody-dependent functional immune responses. npj Vaccines. 2023;8:51.","journal-title":"npj Vaccines"},{"key":"6986_CR16","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nri2868","volume":"10","author":"MF Bachmann","year":"2010","unstructured":"Bachmann MF, Jennings GT. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat Rev Immunol. 2010;10:787\u201396.","journal-title":"Nat Rev Immunol"},{"key":"6986_CR17","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1080\/14760584.2018.1516552","volume":"17","author":"B Donaldson","year":"2018","unstructured":"Donaldson B, Lateef Z, Walker GF, Young SL, Ward VK. Virus-like particle vaccines: immunology and formulation for clinical translation. Expert Rev Vaccines. 2018;17:833\u201349.","journal-title":"Expert Rev Vaccines"},{"key":"6986_CR18","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3389\/fimmu.2017.00226","volume":"8","author":"AC Gomes","year":"2017","unstructured":"Gomes AC, Flace A, Saudan P, Zabel F, Cabral-Miranda G, Turabi AE, et al. Adjusted Particle Size Eliminates the Need of Linkage of Antigen and Adjuvants for Appropriated T Cell Responses in Virus-Like Particle-Based Vaccines. Front Immunol. 2017;8:226.","journal-title":"Front Immunol"},{"key":"6986_CR19","doi-asserted-by":"publisher","first-page":"26770","DOI":"10.1021\/acsnano.4c07360","volume":"18","author":"V Lensch","year":"2024","unstructured":"Lensch V, Hincapie GA, Bhagchandani R, Basak SH, Alam A, Noble MM, et al. LL. Carbohydrate-Lectin Interactions Reprogram Dendritic Cells to Promote Type 1 Anti-Tumor Immunity. ACS nano. 2024;18:26770\u201383.","journal-title":"ACS nano"},{"key":"6986_CR20","doi-asserted-by":"publisher","first-page":"13755","DOI":"10.1021\/acsnano.4c01969","volume":"18","author":"M Yang","year":"2024","unstructured":"Yang M, Rao G, Li L, Qi L, Ma C, Zhang H, et al. Transformation of a Viral Capsid from Nanocages to Nanotubes and Then to Hydrogels: Redirected Self-Assembly and Effects on Immunogenicity. ACS nano. 2024;18:13755\u201367.","journal-title":"ACS nano"},{"key":"6986_CR21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2305896120","volume":"120","author":"P Zhang","year":"2023","unstructured":"Zhang P, Falcone S, Tsybovsky Y, Singh M, Gopan V, Miao H, et al. Increased neutralization potency and breadth elicited by a SARS-CoV-2 mRNA vaccine forming virus-like particles. Proc Natl Acad Sci USA. 2023;120:e2305896120.","journal-title":"Proc Natl Acad Sci USA"},{"key":"6986_CR22","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01030-21","volume":"95","author":"S Panthi","year":"2021","unstructured":"Panthi S, Schmitt PT, Lorenz FJ, Stanfield BA, Schmitt AP. Paramyxovirus-Like Particles as Protein Delivery Vehicles. J Virol. 2021;95:e0103021.","journal-title":"J Virol"},{"key":"6986_CR23","doi-asserted-by":"publisher","first-page":"43621","DOI":"10.1021\/acsami.3c10340","volume":"15","author":"Y Wang","year":"2023","unstructured":"Wang Y, Douglas T. Tuning Multistep Biocatalysis through Enzyme and Cofactor Colocalization in Charged Porous Protein Macromolecular Frameworks. ACS Appl Mater Interfaces. 2023;15:43621\u201332.","journal-title":"ACS Appl Mater Interfaces"},{"key":"6986_CR24","doi-asserted-by":"publisher","first-page":"6509","DOI":"10.1021\/jacs.9b01523","volume":"141","author":"H Cai","year":"2019","unstructured":"Cai H, Shukla S, Wang C, Masarapu H, Steinmetz NF. Heterologous Prime-Boost Enhances the Antitumor Immune Response Elicited by Plant-Virus-Based Cancer Vaccine. J Am Chem Soc. 2019;141:6509\u201318.","journal-title":"J Am Chem Soc"},{"key":"6986_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41551-024-01208-4","volume":"9","author":"D Yin","year":"2025","unstructured":"Yin D, Zhong Y, Ling S, Lu S, Wang X, Jiang Z, et al. Dendritic-cell-targeting virus-like particles as potent mRNA vaccine carriers. Nat Biomed Eng. 2025;9:185\u2013200.","journal-title":"Nat Biomed Eng"},{"key":"6986_CR26","doi-asserted-by":"publisher","first-page":"13474","DOI":"10.1021\/acsnano.3c01829","volume":"17","author":"J Pan","year":"2023","unstructured":"Pan J, Wang Q, Qi M, Chen J, Wu X, Zhang X, et al. An Intranasal Multivalent Epitope-Based Nanoparticle Vaccine Confers Broad Protection against Divergent Influenza Viruses. ACS nano. 2023;17:13474\u201387.","journal-title":"ACS nano"},{"key":"6986_CR27","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/354278a0","volume":"354","author":"RC Liddington","year":"1991","unstructured":"Liddington RC, Yan Y, Moulai J, Sahli R, Benjamin TL, Harrison SC. Structure of simian virus 40 at 3.8-\u00c5 resolution. Nature. 1991;354:278\u201384.","journal-title":"Nature"},{"key":"6986_CR28","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0969-2126(96)00020-2","volume":"4","author":"T Stehle","year":"1996","unstructured":"Stehle T, Gamblin SJ, Yan Y, Harrison SC. The structure of simian virus 40 refined at 3.1 A resolution. Struct (Lond, Engl: 1993). 1996;4:165\u201382.","journal-title":"Struct (Lond, Engl: 1993)"},{"key":"6986_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/biot.201700619","volume":"13","author":"W Zhang","year":"2018","unstructured":"Zhang W, Zhang XE, Li F. Virus-Based Nanoparticles of Simian Virus 40 in the Field of Nanobiotechnology. Biotechnol J. 2018;13:e1700619.","journal-title":"Biotechnol J"},{"key":"6986_CR30","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaz1639","volume":"6","author":"MGM van Rosmalen","year":"2020","unstructured":"van Rosmalen MGM, Kamsma D, Biebricher AS, Li C, Zlotnick A, Roos WH, et al. Revealing in real-time a multistep assembly mechanism for SV40 virus-like particles. Sci Adv. 2020;6:eaaz1639.","journal-title":"Sci Adv"},{"key":"6986_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202004484","volume":"16","author":"C Xu","year":"2020","unstructured":"Xu C, Zhu W, Mao H, Zhang W, Yin GQ, Zhang XE, et al. Switch from Polymorphic to Homogenous Self-Assembly of Virus-Like Particles of Simian Virus 40 through Double-Cysteine Substitution. Small (Weinh der Bergstr, Ger). 2020;16:e2004484.","journal-title":"Small (Weinh der Bergstr, Ger)"},{"key":"6986_CR32","doi-asserted-by":"publisher","first-page":"46850","DOI":"10.1021\/acsami.2c11991","volume":"14","author":"X Feng","year":"2022","unstructured":"Feng X, Gao D, Jing Y, Qian J, Cui Z, Zhou J, et al. Intracellular Delivery of Micron-Sized Magnetic Particles through a Virus Infection Pathway. ACS Appl Mater Interfaces. 2022;14:46850\u20136.","journal-title":"ACS Appl Mater Interfaces"},{"key":"6986_CR33","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1021\/acs.molpharmaceut.1c00704","volume":"19","author":"L Li","year":"2022","unstructured":"Li L, Yan X, Xia M, Shen B, Cao Y, Wu X, et al. Nanoparticle\/Nanocarrier Formulation as an Antigen: The Immunogenicity and Antigenicity of Itself. Mol pharmaceutics. 2022;19:148\u201359.","journal-title":"Mol pharmaceutics"},{"key":"6986_CR34","doi-asserted-by":"publisher","first-page":"5752","DOI":"10.1021\/acsbiomaterials.4c01005","volume":"10","author":"R Lu","year":"2024","unstructured":"Lu R, Lee BJ, Lee E. Three-Dimensional Lymphatics-on-a-Chip Reveals Distinct, Size-Dependent Nanoparticle Transport Mechanisms in Lymphatic Drug Delivery. ACS Biomater Sci Eng. 2024;10:5752\u201363.","journal-title":"ACS Biomater Sci Eng"},{"key":"6986_CR35","doi-asserted-by":"publisher","first-page":"6472","DOI":"10.1016\/j.vaccine.2016.11.008","volume":"34","author":"A Seth","year":"2016","unstructured":"Seth A, Kong IG, Lee SH, Yang JY, Lee YS, Kim Y, et al. Modular virus-like particles for sublingual vaccination against group A streptococcus. Vaccine. 2016;34:6472\u201380.","journal-title":"Vaccine"},{"key":"6986_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-02116-6","volume":"21","author":"X Liu","year":"2023","unstructured":"Liu X, Min Q, Song H, Yue A, Li Q, Zhou Q, et al. Potentiating humoral and cellular immunity using a novel hybrid polymer-lipid nanoparticle adjuvant for HBsAg-VLP vaccine. J Nanobiotechnol. 2023;21:441.","journal-title":"J Nanobiotechnol"},{"key":"6986_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2025.115296","volume":"259","author":"H Tan","year":"2025","unstructured":"Tan H, Tang M, Che Y, Li X, Tu Z, Zhao X, et al. Virus like nanoparticles of VLP-BSA-iRGD enhanced mucosal immune response by targeting M cells. Colloids Surf B, Biointerfaces. 2025;259:115296.","journal-title":"Colloids Surf B, Biointerfaces"},{"key":"6986_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2024.1460973","volume":"11","author":"S Su","year":"2024","unstructured":"Su S, Shen X, Shi X, Li X, Chen J, Yang W, et al. Cell-penetrating peptides TAT and 8R functionalize P22 virus-like particles to enhance tissue distribution and retention in vivo. Front Vet Sci. 2024;11:1460973.","journal-title":"Front Vet Sci"},{"key":"6986_CR39","doi-asserted-by":"publisher","first-page":"12659","DOI":"10.2147\/IJN.S548334","volume":"20","author":"S Liang","year":"2025","unstructured":"Liang S, Chi YX, Wang Y, Ma K, Yang L, Xue Z, et al. J. Multifunctional HBc Virus-Like Particles Reprogram Immunosuppressive Macrophages and Potentiate CD8(+) T Cell Responses for Enhanced Cancer Immunotherapy. Int J Nanomed. 2025;20:12659\u201379.","journal-title":"Int J Nanomed"},{"key":"6986_CR40","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/7403","volume":"5","author":"NC Fernandez","year":"1999","unstructured":"Fernandez NC, Lozier A, Flament C, Ricciardi-Castagnoli P, Bellet D, Suter M, et al. Dendritic cells directly trigger NK cell functions: Cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med. 1999;5:405\u201311.","journal-title":"Nat Med"},{"key":"6986_CR41","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1038\/s41590-024-01884-z","volume":"25","author":"H Netskar","year":"2024","unstructured":"Netskar H, Pfefferle A, Goodridge JP, Sohlberg E, Dufva O, Teichmann SA, et al. Pan-cancer profiling of tumor-infiltrating natural killer cells through transcriptional reference mapping. Nat Immunol. 2024;25:1445\u201359.","journal-title":"Nat Immunol"},{"key":"6986_CR42","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/356796a0","volume":"356","author":"R K\u00f6nig","year":"1992","unstructured":"K\u00f6nig R, Huang L-Y, Germain RN. MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8. Nature. 1992;356:796\u20138.","journal-title":"Nature"},{"key":"6986_CR43","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s43018-023-00521-2","volume":"4","author":"DE Speiser","year":"2023","unstructured":"Speiser DE, Chijioke O, Schaeuble K, M\u00fcnz C. CD4+ T cells in cancer. Nat Cancer. 2023;4:317\u201329.","journal-title":"Nat Cancer"},{"key":"6986_CR44","doi-asserted-by":"publisher","DOI":"10.1126\/science.abe6474","volume":"374","author":"L Zheng","year":"2021","unstructured":"Zheng L, Si QS, Wang W, Xing A, Gao B, Ren R, et al. Z. Pan-cancer single-cell landscape of tumor-infiltrating T cells. Science (N Y, NY). 2021;374:abe6474.","journal-title":"Science (N Y, NY)"},{"key":"6986_CR45","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41586-024-08076-7","volume":"636","author":"MA Cardenas","year":"2024","unstructured":"Cardenas MA, Prokhnevska N, Sobierajska E, Gregorova P, Medina CB, Valanparambil RM, et al. Differentiation fate of a stem-like CD4 T cell controls immunity to cancer. Nature. 2024;636:224\u201332.","journal-title":"Nature"},{"key":"6986_CR46","doi-asserted-by":"crossref","unstructured":"Viscidi RP, Rowley T, Bossis I. Bioengineered Bovine Papillomavirus L1 Protein Virus-like Particle (VLP) Vaccines for Enhanced Induction of CD8 T Cell Responses through Cross-Priming. Int J Mol Sci. 2023;24:9851.","DOI":"10.3390\/ijms24129851"},{"key":"6986_CR47","doi-asserted-by":"publisher","first-page":"10482","DOI":"10.1021\/acsnano.2c01283","volume":"16","author":"M Li","year":"2022","unstructured":"Li M, Chen LZ, Yu C, Yao G, Guo Z, Zhang Y, et al. B. Virus-Like Particle-Templated Silica-Adjuvanted Nanovaccines with Enhanced Humoral and Cellular Immunity. ACS nano. 2022;16:10482\u201395.","journal-title":"ACS nano"},{"key":"6986_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12896-016-0285-6","volume":"16","author":"Y Xiao","year":"2016","unstructured":"Xiao Y, Chen HY, Wang Y, Yin B, Lv C, Mo X, et al. Large-scale production of foot-and-mouth disease virus (serotype Asia1) VLP vaccine in Escherichia coli and protection potency evaluation in cattle. BMC Biotechnol. 2016;16:56.","journal-title":"BMC Biotechnol"},{"key":"6986_CR49","doi-asserted-by":"crossref","unstructured":"Kim H, Kim D-W, Cho G, Hwang J-H, Chae Y, Kim T, et al. Neutralizing Antibody Screening Using NanoBiT-Based Virus-like Particles of Foot-and-Mouth Disease Type Asia1 Enhances Biosafety and Sensitivity. Viruses. 2025;17:337.","DOI":"10.3390\/v17030337"},{"key":"6986_CR50","doi-asserted-by":"publisher","first-page":"8720","DOI":"10.1128\/JVI.01239-16","volume":"90","author":"D Li","year":"2016","unstructured":"Li D, Chen T, Hu Y, Zhou Y, Liu Q, Zhou D, et al. An Ebola Virus-Like Particle-Based Reporter System Enables Evaluation of Antiviral Drugs In Vivo under Non-Biosafety Level 4 Conditions. J Virol. 2016;90:8720\u20138.","journal-title":"J Virol"},{"key":"6986_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1178382","volume":"10","author":"E Robilotti","year":"2023","unstructured":"Robilotti E, Zeitouni NC, Orloff M. Biosafety and biohazard considerations of HSV-1-based oncolytic viral immunotherapy. Front Mol Biosci. 2023;10:1178382.","journal-title":"Front Mol Biosci"},{"key":"6986_CR52","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrd3003","volume":"9","author":"TT Hansel","year":"2010","unstructured":"Hansel TT, Kropshofer H, Singer T, Mitchell JA, George AJT. The safety and side effects of monoclonal antibodies. Nat Rev Drug Discov. 2010;9:325\u201338.","journal-title":"Nat Rev Drug Discov"},{"key":"6986_CR53","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/PPO.0000000000000035","volume":"20","author":"SL Maude","year":"2014","unstructured":"Maude SL, Barrett D, Teachey DT, Grupp SA. Managing cytokine release syndrome associated with novel T cell-engaging therapies. Cancer J. 2014;20:119\u201322.","journal-title":"Cancer J"},{"key":"6986_CR54","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/d41586-018-07581-w","volume":"564","author":"RI SR","year":"2018","unstructured":"SR RI. Adrenaline fuels a cytokine storm during immunotherapy. Nature. 2018;564:194\u20136.","journal-title":"Nature"},{"key":"6986_CR55","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1021\/acsnano.0c03023","volume":"15","author":"MM Alam","year":"2021","unstructured":"Alam MM, Hincapie JC, McKay R, Schimer CS, Sanhueza J, Xu CA, et al. LL. Glycan-Modified Virus-like Particles Evoke T Helper Type 1-like Immune Responses. ACS nano. 2021;15:309\u201321.","journal-title":"ACS nano"},{"key":"6986_CR56","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41551-023-01131-0","volume":"8","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Ma J, Shen R, Lin J, Li S, Lu X, et al. Screening for lipid nanoparticles that modulate the immune activity of helper T cells towards enhanced antitumour activity. Nat Biomed Eng. 2024;8:544\u201360.","journal-title":"Nat Biomed Eng"},{"key":"6986_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49034-1","volume":"15","author":"Z Zou","year":"2024","unstructured":"Zou Z, Shen J, Xue D, Li H, Xu L, Cao W, et al. Anti-PD-1 cis-delivery of low-affinity IL-12 activates intratumoral CD8+T cells for systemic antitumor responses. Nat Commun. 2024;15:4701.","journal-title":"Nat Commun"},{"key":"6986_CR58","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/s41586-024-08426-5","volume":"638","author":"M Amisaki","year":"2025","unstructured":"Amisaki M, Zebboudj A, Yano H, Zhang SL, Payne G, Chandra AK, et al. IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancer. Nature. 2025;638:1076\u201384.","journal-title":"Nature"},{"key":"6986_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41438-9","volume":"14","author":"X Zhang","year":"2023","unstructured":"Zhang X, Wei Z, Yong T, Li S, Bie N, Li J, et al. Cell microparticles loaded with tumor antigen and resiquimod reprogram tumor-associated macrophages and promote stem-like CD8+ T cells to boost anti-PD-1 therapy. Nat Commun. 2023;14:5653.","journal-title":"Nat Commun"}],"container-title":["Journal of Materials Science: Materials in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10856-025-06986-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10856-025-06986-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10856-025-06986-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T14:02:58Z","timestamp":1767880978000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10856-025-06986-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6986"],"URL":"https:\/\/doi.org\/10.1007\/s10856-025-06986-0","relation":{},"ISSN":["1573-4838"],"issn-type":[{"value":"1573-4838","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]},"assertion":[{"value":"21 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"15"}}